SEC recommends granting emergency use authorisation to Serum...
SEC recommends COVID-19 vaccine Corbevax for 12-18 year age...
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee...
Subject expert committee recommends Russia's Sputnik Light...
New Delhi [India], February 5 (ANI): The subject expert committee under India's drug regulator has recommended...
COVID-19: Nasal vaccine could be a game-changer if it...
SEC recommends regular market approval to Covaxin, Covishield...
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee...
SEC asks for more data to grant full market approval to...
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee...
DCGI's SEC to review applications of Bharat Biotech, SII for...
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will...
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
SEC recommends emergency use authorization of Covovax,...
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee...
SEC to take decision on antiviral Covid pill today
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject...
No recommendations for COVID-19 booster dose by SEC: Sources
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control...
Subject Expert Committee to meet tomorrow to discuss approval...
Copyright © aninews.in | All Rights Reserved.